Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alpha Cognition Inc (ACOG.CN)

Alpha Cognition Inc (ACOG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alpha Cognition Inc 1200 - 750 West Pender Street Vancouver BC V6C 2T8 CAN

https://www.alphacognition.com P: 604-564-9244

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Key Statistics

Overview:

Market Capitalization, $K 126,735
Shares Outstanding, K 15,531

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -14,637 K
Last Quarter Sales, $ 2,841 K
Last Quarter Net Income, $ -1,318 K

Growth:

1-Year Return -48.19%
3-Year Return -70.06%
5-Year Return 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 11/14/24
Next Earnings Date N/A
Earnings Per Share ttm -3.03
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -21.06%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 11/05/24

ACOG.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -125.65%
Return-on-Assets % -75.87%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book N/A
Book Value/Share -0.27
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar